In the paper, Dickos (2011) gives a detail account of the background of the science behind the various genetic engineered animals. The current regulatory framework existing through agencies like FDA is examined and exhorts that its authority to regulate new animal drugs (NADs) should be fully implemented. The paper examines the problems with the current regulatory scheme in the light of three recent examples concerning the GE animals. Starting with the first commercial GE food the Flavr Savr tomato in 1994, human beings have manipulated the genetic makeup of more than 60 plants and animals to introduce both agriculturally beneficial traits like disease and pest resistance and also for nutritional benefits like modified oil in soybean. While GE organisms opens up innumerable benefits including mass production of beneficial hormones and proteins and increasing the nutritional value of the product, Dickos (2011) also warns the risk of unintended effects of the manipulated genes which can result in the formation of changed metabolites and also health risks like toxicity, environmental risk and can prove to be harmful for the animal itself. The paper provides the case study of three GE animals the GloFish as pet, the ATryn Goat as drug and, the AquAdvantage Salmon as food provide prime examples for evaluating FDA’s 2009 Guidance and it also raises the concern of non-labeling of GE products by FDA. Dick also provides necessary recommendation for proper governance of development and use of GE animals and products.
A similar article about the development of genetically modified cows to produce healthier milk was reported in The Telegraph (2012, June 17) by Richard Gray. Genetically modified cow capable of producing milk which can be consumed even by people with lactose intolerance and a second animal whose milk